PDIA3 Inhibition Facilitates Sensitivity of IKE‐Induced Ferroptosis via STAT3/LCN2 Axis to Improve Glioblastoma Therapy
Advanced Science · 2026
DOI: 10.1002/advs.202514191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Jie Zhang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences College & Shandong Medicinal Biotechnology Center, Shandong First Medical University & Shandong Academy of Medical Science, Jinan…. Hauptthemen laut MEDLINE: Ferroptosis, Glioblastoma, STAT3 Transcription Factor, Protein Disulfide-Isomerases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, 2024 Talent Project of Shandong First Medical University.
Abstract (Originalsprache)
Ferroptosis, an iron‐dependent form of programmed cell death, has emerged as a promising therapeutic approach in glioblastoma (GBM). Nonetheless, the role and mechanism governing vulnerability to ferroptosis in GBM have remained unknown. In this study, we identify protein disulfide isomerase A3 (PDIA3) as a crucial factor mediating the vulnerability of glioma cells to ferroptosis and demonstrate that inhibition or depletion of PDIA3 enhances IKE‐induced ferroptosis in GBM cells. Mechanistically, NEDD4L functions as an E3 ubiquitin ligase to promote ferroptosis by facilitating K29‐linked ubiquitination of PDIA3 via its C‐terminal HECT domain. Furthermore, NEDD4L‐mediated ubiquitination of PDIA3 enhances ferroptosis by downregulating the expression of LCN2 through its interaction with STAT3 independently of ATF4. Here, a drug delivery system is presented using a tetrahedral DNA nanostructure (TDN) encapsulating IKE (TDN‐IKE) to penetrate the blood–brain barrier. The combined use of TDN‐IKE and PDIA3 inhibitors exhibits a synergistic antitumor effect against GBM therapy in vivo, providing a potential therapeutic approach for ferroptosis‐based therapy in GBM. Overall, these findings demonstrate a novel mechanism by which PDIA3 regulates ferroptosis, indicating that a promising therapeutic strategy for GBM is through inhibiting of SLC7A11 and PDIA3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Sciences College & Shandong Medicinal Biotechnology Center, Shandong First Medical University & Shandong Academy of Medical Science, Jinan, Shandong, 250117, China.
- Cancer Biology Institute, Baotou Medical College, Inner Mongolia Autonomous Region, Baotou, 014040, China.
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Science, Jinan, Shandong, 250117, China.
- School of Life Science, Shandong First Medical University & Shandong Academy of Medical Science, Tai'an, Shandong, 271016, China.
- Department of Biochemistry and Biophysics, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191,…
- Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250117, China.
ORCID-Profile: Yiju Wei
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- 2024 Talent Project of Shandong First Medical University
- Central Guidance for Local Science and Technology
- Inner Mongolia Science and Technology Plan
- Taishan Scholar Foundation of Shandong Province
- Shandong Province Medical and Health Technology Project
Zitieren
APA
Zhang, J., Wang, W., Liu, X., Lu, P., Liu, X., Nie, Q., Xin, S., Li, H., Yu, D., Zhang, X., Li, K., Han, X., Zhang, S., Chong, W., Sun, L., Li, W., Xin, T., Jiao, J., Ma, Q., & Wei, Y. (2026). PDIA3 Inhibition Facilitates Sensitivity of IKE‐Induced Ferroptosis via STAT3/LCN2 Axis to Improve Glioblastoma Therapy. Advanced Science. https://doi.org/10.1002/advs.202514191
Vancouver
Zhang J, Wang W, Liu X, Lu P, Liu X, Nie Q, et al. PDIA3 Inhibition Facilitates Sensitivity of IKE‐Induced Ferroptosis via STAT3/LCN2 Axis to Improve Glioblastoma Therapy. Advanced Science. 2026. doi:10.1002/advs.202514191
BibTeX
@article{Zhang2026,
author = {Zhang, Jie and Wang, Wei and Liu, Xin and Lu, Peifen and Liu, Xinjing and Nie, Qiucheng and Xin, Siyuan and Li, Hong and Yu, Donglin and Zhang, Xinyue and Li, Kailong and Han, Xiaomin and Zhang, Shuping and Chong, Wei and Sun, Lili and Li, Wei and Xin, Tao and Jiao, Jin and Ma, Qiang and Wei, Yiju},
title = {PDIA3 Inhibition Facilitates Sensitivity of IKE‐Induced Ferroptosis via STAT3/LCN2 Axis to Improve Glioblastoma Therapy},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202514191}
}
EUVIMED